NSF Dear Colleague Letter: Posttranscriptional and Posttranslational Modification (PPM) - No Deadline
NAS Report “Charting a Future for sequencing RNA and its modifications”
https://nap.nationalacademies.org/read/27165/chapter/1
RFA-CA-24-029 RNA Modifications Driving Oncogenesis
Posted Date: July 29, 2024
Open Date (Earliest Submission Date): October 04, 2024
Letter of Intent Due Date(s): October 05, 2024
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-029.html
RFA-AG-25-023 Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD
Posted Date: July 31, 2024
Open Date (Earliest Submission Date): October 01, 2024
Letter of Intent Due Date(s): October 01, 2024
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-029.html
Notice of Pre-Application Webinar for RFA-CA-24-029, "RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)" Program
(NOT-CA-24-101)
National Cancer Institute
Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
(RFA-AI-24-057)
National Institute of Allergy and Infectious Diseases
Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
(RFA-AI-24-064)
National Institute of Allergy and Infectious Diseases